down arrow

Gland Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Raw Material Cost
2,022.14
1,716.75
2,046.86
1,749.16
1,090.25
Purchase of Finished goods
23.07
15.59
25.67
16.20
18.67
(Increase) / Decrease In Stocks
127.89
-46.92
36.69
-273.49
-6.90
Employee Cost
1,256.89
403.26
338.57
311.36
277.66
Power Cost
229.99
124.84
95.05
74.59
78.50
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
671.68
386.31
347.71
282.83
219.59
Total Expenditure (Excl Depreciation)
4,331.65
2,599.83
2,890.55
2,160.65
1,677.77
Operating Profit (PBDIT) excl Other Income
1,333.07
1,024.77
1,510.16
1,302.23
955.47
Other Income
170.24
240.46
223.94
134.78
139.17
Operating Profit (PBDIT)
1,503.31
1,265.23
1,734.10
1,437.01
1,094.64
Interest
26.20
7.45
5.24
3.41
7.18
Exceptional Items
0.00
-56.46
0.00
0.00
0.00
Gross Profit (PBDT)
1,477.11
1,201.32
1,728.86
1,433.60
1,087.46
Depreciation
344.57
146.74
110.30
98.78
94.59
Profit Before Tax
1,132.54
1,054.58
1,618.55
1,334.81
992.87
Tax
360.08
273.54
406.89
337.85
220.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
772.46
781.04
1,211.66
996.96
772.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
772.46
781.04
1,211.66
996.96
772.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
772.46
781.04
1,211.66
996.96
772.86
Equity Capital
16.47
16.47
16.43
16.36
15.50
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
8,707.37
7,942.25
7,141.19
5,886.88
3,630.74
Earnings per share (EPS)
46.9
47.42
73.75
60.94
49.86
Diluted Earnings per share
46.89
47.43
73.64
62.99
49.88
Operating Profit Margin (Excl OI)
23.53%
28.27%
34.32%
37.61%
36.28%
Gross Profit Margin
26.08%
33.14%
39.29%
41.4%
41.3%
PAT Margin
13.64%
21.55%
27.53%
28.79%
29.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 30.08% vs -32.14% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 251.68% vs 42.18% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Gland Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
5,664.72
10,334.77
-4,670.05
-45.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,664.72
10,334.77
-4,670.05
-45.19%
Raw Material Cost
2,022.14
1,853.52
168.62
9.10%
Purchase of Finished goods
23.07
1,409.85
-1,386.78
-98.36%
(Increase) / Decrease In Stocks
127.89
-53.67
181.56
338.29%
Employee Cost
1,256.89
2,274.73
-1,017.84
-44.75%
Power Cost
229.99
0.00
229.99
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
671.68
2,315.28
-1,643.60
-70.99%
Total Expenditure (Excl Depreciation)
4,331.65
7,799.71
-3,468.06
-44.46%
Operating Profit (PBDIT) excl Other Income
1,333.07
2,535.06
-1,201.99
-47.41%
Other Income
170.24
280.86
-110.62
-39.39%
Operating Profit (PBDIT)
1,503.31
2,815.92
-1,312.61
-46.61%
Interest
26.20
33.53
-7.33
-21.86%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,477.11
2,782.39
-1,305.28
-46.91%
Depreciation
344.57
398.25
-53.68
-13.48%
Profit Before Tax
1,132.54
2,384.14
-1,251.60
-52.50%
Tax
360.08
457.58
-97.50
-21.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
772.46
1,926.56
-1,154.10
-59.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
772.46
1,926.56
-1,154.10
-59.90%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
772.46
1,912.90
-1,140.44
-59.62%
Equity Capital
16.47
40.06
-23.59
-58.89%
Face Value
1.00
1.00
0.00
Reserves
8,707.37
9,323.03
-615.66
-6.60%
Earnings per share (EPS)
46.90
47.75
-0.85
-1.78%
Diluted Earnings per share
46.89
47.68
-0.79
-1.66%
Operating Profit Margin (Excl OI)
23.53%
24.53%
0.00
-1.00%
Gross Profit Margin
26.08%
26.92%
0.00
-0.84%
PAT Margin
13.64%
18.79%
0.00
-5.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 5,664.72 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 772.46 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,333.07 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 30.08% vs -32.14% in Mar 2023

Annual - Interest
Interest 26.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 251.68% vs 42.18% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.53%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023